Bioavailability Contract Manufacturing Drug Delivery Systems Production 
Roots Analysis
FEBRUARY 20, 2022
Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility.
Roots Analysis
MARCH 13, 2022
In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. Therefore, a variety of excipients, which are pharmacologically inert substances themselves, are used to stabilize biologics during the manufacturing process and storage. Our Social Media Platform. Web: [link]. Twitter: [link].
Expert insights. Personalized for you.
52 
Let's personalize your content